Aktie A0MVLF SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sun Pharma Advanced Research Company Limited

Aktien

A0MVLF

INE232I01014

SPARC

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 13:43:53 22.05.2024 		% 5 Tage % 1. Jan.
211,4 INR -2,02 % Intraday Chart für Sun Pharma Advanced Research Company Limited -3,62 % -26,27 %
15.04. Transcript : Sun Pharma Advanced Research Company Limited - Special Call
10.04. Sun Pharma Advanced Research Company Limited gibt Ergebnisse der geplanten Zwischenanalyse der PROSEEK-Studie zu Vodobatinib bei Patienten mit früher Parkinson-Krankheit bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Ocular Hypertension Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitecap Biosciences, and others.
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Sun Pharma Advanced Research Company Limited Announces Retirement of Chitturi Trinadha Rao as Senior Vice President, Drug Discovery
Sun Pharma Advanced Research : Update on Clinical Programs and R&D Pipeline
Sun Pharma Advanced Research : SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB
Sun Pharma Advanced Research : SPARC Completes Enrolment in PROSEEK, A Global Phase 2 Study of Vodobatinib in Early Parkinson’s Disease
Sun Pharma Advanced Research Company Ltd. Completes Enrolment in Proosek, A Global Phase 2 Study of Vodobatinib in Early Parkinson's Disease
Sun Pharma Advanced Research : SPARC to Provide Update on Clinical Programs and R&D Pipeline
Sun Pharma Advanced Research Company Limited Announces Incorporation of Wholly Owned Subsidiary Company
Sun Pharma Advanced Research Company Limited Appoints Kajal Damania as Company Secretary
Sun Pharma Advanced Research Company Limited Announces the Resignation of Mr. Dinesh Lahoti as Company Secretary and Compliance Officer
Sun Pharma Advanced Research : AGM Speech 2022-23
Sun Pharma Advanced Research Company Limited Announces Resignation of Dinesh Lahoti as Company Secretary and Compliance Officer, Effective September 11, 2023
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Sun Pharma Advanced Research : FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility
Sun Pharma Advanced Research Company Limited Announces That FDA Issues Complete Response Letter for Pdp-716 Nda Due to Inspection Findings At Third-Party Api Manufacturing Facility
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Indian shares open higher as SVB acquisition hopes aid sentiment
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0MVLF Aktie
  4. Nachrichten Sun Pharma Advanced Research Company Limited
  5. Andere Sprachen